Xiao-ran Liu

发表

Efficacy of platinum in advanced triple-negative breast cancer with germline BRCA mutation determined by next generation sequencing

J. Yu, Huiping Li, Jianjun Yu, 2020, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

Identification of high independent prognostic value of nanotechnology based circulating tumor cell enumeration in first-line chemotherapy for metastatic breast cancer patients.

B. Shao, Huiping Li, G. Song, 2017, Breast.

HER2 Phenotyping of CTCs By Peptide-Functionalized Nanoparticles As The Diagnostic Biomarkers of Anti-HER2 Treatment in Breast Cancer

B. Shao, Huiping Li, Ping Li, 2021 .

BRG1 promotes chemoresistance of pancreatic cancer cells through crosstalking with Akt signalling.

M. Kornmann, Yinmo Yang, X. Tian, 2014, European journal of cancer.

Identification of mutation patterns and circulating tumour DNA-derived prognostic markers in advanced breast cancer patients

B. Shao, Huiping Li, Jianjun Yu, 2022, Journal of Translational Medicine.

Efficacy and Safety of Initial 5 Years of Adjuvant Endocrine Therapy in Postmenopausal Hormone Receptor-Positive Breast Cancer: A Systematic Review and Network Meta-Analysis

H. Rugo, B. Shao, Huiping Li, 2022, Frontiers in Pharmacology.

Current situation of programmed cell death protein 1/programmed cell death ligand 1 inhibitors in advanced triple-negative breast cancer

Huiping Li, Kun Li, Xiao-ran Liu, 2022, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

Combination versus sequential paclitaxel plus gemcitabine as first-line chemotherapy for women with metastatic breast cancer: a prospective randomized phase II study.

B. Shao, Huiping Li, G. Song, 2018, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Combined peripheral natural killer cell and circulating tumor cell enumeration enhance prognostic efficiency in patients with metastatic triple-negative breast cancer.

Zhiyuan Hu, H. Rugo, B. Shao, 2018, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

HER2 status of CTCs by peptide-functionalized nanoparticles as the diagnostic biomarker of breast cancer and predicting the efficacy of anti-HER2 treatment

B. Shao, Huiping Li, Ling Zhu, 2022, Frontiers in Bioengineering and Biotechnology.

Prognostic Value of Pretreatment Neutrophil-to-Lymphocyte Ratio in HER2-Positive Metastatic Breast Cancer

B. Shao, Huiping Li, L. Di, 2022, Current oncology.

The prognostic value of chemotherapy or endocrine therapy choice according to circulating tumor cell count in HR+HER2− metastatic breast cancer: a retrospective study

B. Shao, Huiping Li, L. Di, 2022, Annals of translational medicine.

Identification of recurrent BRCA1 mutation and its clinical relevance in Chinese Triple‐negative breast cancer cohort

B. Shao, Huiping Li, Jianmin Wu, 2017, Cancer medicine.

Cell-free DNA comparative analysis of the genomic landscape of first-line hormone receptor-positive metastatic breast cancer from the US and China

Huiping Li, M. Cristofanilli, Qiang Zhang, 2020, Breast Cancer Research and Treatment.

Cell-free DNA comparative analysis of genomic landscape of rst-line hormone-receptor positive metastatic breast cancer from US and China

Huiping Li, Xiao-ran Liu, Youbin Zhang, 2021 .

Efficacy and safety of trastuzumab combined with chemotherapy for first-line treatment and beyond progression of HER2-overexpressing advanced breast cancer

B. Shao, Huiping Li, G. Song, 2016, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

Plasma microRNAs Predict Chemoresistance in Patients With Metastatic Breast Cancer

B. Shao, Huiping Li, Xiaoxia Wang, 2019, Technology in cancer research & treatment.

A prospective study of chemoradiotherapy for early stage extranodal natural killer ( NK ) / T-cell lymphoma

Hongwei Xue, F. Zhou, Hongsheng Yu, 2016 .

Hedgehog Signaling Regulates Epithelial-Mesenchymal Transition in Pancreatic Cancer Stem-Like Cells

M. Kornmann, Ling Ma, Yinmo Yang, 2016, Journal of Cancer.

Pegylated liposomal doxorubicin (Duomeisu®) monotherapy in patients with HER2-negative metastatic breast cancer heavily pretreated with anthracycline and taxanes: a single-arm, phase II study

Huan Wang, B. Shao, Huiping Li, 2023, Breast Cancer Research and Treatment.

Prognostic Value of the TP53 Mutation Location in Metastatic Breast Cancer as Detected by Next-Generation Sequencing

Huiping Li, Jianjun Yu, S. Jia, 2021, Cancer management and research.

Peripheral cytotoxic T lymphocyte predicts first-line progression free survival in HER2-positive advanced breast cancer

J. Yu, Huiping Li, Jianjun Yu, 2020, Breast.

Prognostic Value of Plasma HER2 Gene Copy Number in HER2-Positive Metastatic Breast Cancer Treated with First-Line Trastuzumab

H. Rugo, Huiping Li, Shiping Bo, 2020, OncoTargets and therapy.

Methylome Variation Predicts Exemestane Resistance in Advanced ER+ Breast Cancer

H. Rugo, B. Shao, Huiping Li, 2020, Technology in cancer research & treatment.

Peptide-Functionalized Nanomaterials for the Efficient Isolation of HER2-Positive Circulating Tumor Cells.

B. Shao, Huiping Li, Chen Wang, 2017, ACS applied materials & interfaces.

Phase I dose-escalation and expansion study of PARP inhibitor, fluzoparib (SHR3162), in patients with advanced solid tumors

H. Rugo, B. Shao, Huiping Li, 2020, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

Clinical outcomes with first-line chemotherapy versus endocrine therapy for adjuvant endocrine therapy-resistant metastatic breast cancer

B. Shao, Huiping Li, Jinrong Qu, 2018, Translational Cancer Research.

Precisely Enumerating Circulating Tumor Cells Utilizing a Multi-Functional Microfluidic Chip and Unique Image Interpretation Algorithm

Hui Zheng, Ren Li, Zhaoba Wang, 2017, Theranostics.

Noninvasive Diagnosis and Molecular Phenotyping of Breast Cancer through Microbead-Assisted Flow Cytometry Detection of Tumor-Derived Extracellular Vesicles

B. Shao, Huiping Li, Chen Wang, 2018, Small Methods.

BRM/SMARCA2 promotes the proliferation and chemoresistance of pancreatic cancer cells by targeting JAK2/STAT3 signaling.

M. Kornmann, Ling Ma, Yinmo Yang, 2017, Cancer letters.

Clinicopathological features and prognosis of patients with pregnancy‐associated breast cancer: A matched case control study

B. Shao, Huiping Li, L. Di, 2021, Asia-Pacific Journal of Clinical Oncology.

Bilateral breast cancer in China: A 10‐year single‐center retrospective study (2006–2016)

B. Shao, Huiping Li, L. Di, 2021, Cancer medicine.

LDR reverses DDP resistance in ovarian cancer cells by affecting ERCC-1, Bcl-2, Survivin and Caspase-3 expressions.

T. Jiang, Hongsheng Yu, Yuanwei Liu, 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Low-dose radiation reverses cisplatin resistance in ovarian cancer cells by changing Survivin and Caspase-3 expression

T. Jiang, Hongsheng Yu, Xiao-ran Liu, 2016 .

Clinicopathologic features, genomic profiles and outcomes of younger vs. older Chinese hormone receptor-positive (HR+)/HER2-negative (HER2-) metastatic breast cancer patients

Y. Liang, Huiping Li, Jianjun Yu, 2023, Frontiers in Oncology.

Efficacy of apatinib 250 mg combined with chemotherapy in patients with pretreated advanced breast cancer in a real-world setting

B. Shao, Huiping Li, A. Zhu, 2023, Frontiers in Oncology.

Persistence of peripheral CD8 + CD28− T cells indicates a favourable outcome and tumour immunity in first-line HER2-positive metastatic breast cancer

B. Shao, Huiping Li, S. Jia, 2024, British journal of cancer.

Variant allele frequency in circulating tumor DNA correlated with tumor disease burden and predicted outcomes in patients with advanced breast cancer

B. Shao, Huiping Li, S. Jia, 2024, Breast cancer research and treatment.